The Discounted Cash Flow (DCF) valuation of Bristol-Myers Squibb Co (BMY) is 67.43 USD. With the latest stock price at 54.00 USD, the upside of Bristol-Myers Squibb Co based on DCF is 24.9%.
Based on the latest price of 54.00 USD and our DCF valuation, Bristol-Myers Squibb Co (BMY) is a buy. buying Bmy stocks now will result in a potential gain of 24.9%.
| Range | Selected | |
| WACC / Discount Rate | 5.7% - 7.3% | 6.5% |
| Long-term Growth Rate | 0.5% - 1.5% | 1.0% |
| Fair Price | 52.69 - 91.12 | 67.43 |
| Upside | -2.4% - 68.7% | 24.9% |